Leveraging GLP1R and GIPR as molecular addresses for precision beta cell therapy/regeneration during type 1 diabetes

Project Details

Short title Leveraging GLP1R and GIPR as molecular addresses for precision beta cell therapy/regeneration during type 1 diabetes
StatusActive
Effective start/end date1/03/2428/02/29

Funding

  • Diabetes Uk